Correlation Between Edwards Lifesciences and Smith Nephew

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and Smith Nephew at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and Smith Nephew into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences Corp and Smith Nephew SNATS, you can compare the effects of market volatilities on Edwards Lifesciences and Smith Nephew and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of Smith Nephew. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and Smith Nephew.

Diversification Opportunities for Edwards Lifesciences and Smith Nephew

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Edwards and Smith is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and Smith Nephew SNATS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Smith Nephew SNATS and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with Smith Nephew. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Smith Nephew SNATS has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and Smith Nephew go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and Smith Nephew

Allowing for the 90-day total investment horizon Edwards Lifesciences Corp is expected to under-perform the Smith Nephew. But the stock apears to be less risky and, when comparing its historical volatility, Edwards Lifesciences Corp is 1.13 times less risky than Smith Nephew. The stock trades about -0.19 of its potential returns per unit of risk. The Smith Nephew SNATS is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  2,559  in Smith Nephew SNATS on January 26, 2024 and sell it today you would lose (102.00) from holding Smith Nephew SNATS or give up 3.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Edwards Lifesciences Corp  vs.  Smith Nephew SNATS

 Performance 
       Timeline  
Edwards Lifesciences Corp 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Edwards Lifesciences showed solid returns over the last few months and may actually be approaching a breakup point.
Smith Nephew SNATS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Smith Nephew SNATS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Edwards Lifesciences and Smith Nephew Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and Smith Nephew

The main advantage of trading using opposite Edwards Lifesciences and Smith Nephew positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, Smith Nephew can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Smith Nephew will offset losses from the drop in Smith Nephew's long position.
The idea behind Edwards Lifesciences Corp and Smith Nephew SNATS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments